• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Putative elongation factor 1-alpha-like 3 (EEF1A1P5)

ACP16750

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP16750 Target NameEEF1A1P5
Target SynonymsEEF1A1P5; EEF1AL3Putative elongation factor 1-alpha-like 3; EF-1-alpha-like 3; Eukaryotic elongation factor 1 A-like 3; eEF1A-like 3; Eukaryotic translation elongation factor 1 alpha-1 pseudogene 5FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range2-462
Protein LengthFull?Length?of?Mature?ProteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ5VTE0
Background Information
  • Uniprot Id

    Q5VTE0

  • Target Species

    Human

  • Target Name

    EEF1A1P5

  • Target Full Name

    Putative elongation factor 1-alpha-like 3

  • Target Function

    This protein promotes the GTP-dependent binding of aminoacyl-tRNA to the A-site of ribosomes during protein biosynthesis.

  • Target Subcellular Location

    Cytoplasm.

  • Target Protein Families

    TRAFAC class translation factor GTPase superfamily, Classic translation factor GTPase family, EF-Tu/EF-1A subfamily

  • Target Synonyms

    EEF1A1P5; EEF1AL3Putative elongation factor 1-alpha-like 3; EF-1-alpha-like 3; Eukaryotic elongation factor 1 A-like 3; eEF1A-like 3; Eukaryotic translation elongation factor 1 alpha-1 pseudogene 5

Inquire Recombinant Human Putative elongation factor 1-alpha-like 3 (EEF1A1P5) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification